Your browser doesn't support javascript.
loading
Inactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responses.
Muller, David A; Pearson, Frances E; Fernando, Germain J P; Agyei-Yeboah, Christiana; Owens, Nick S; Corrie, Simon R; Crichton, Michael L; Wei, Jonathan C J; Weldon, William C; Oberste, M Steven; Young, Paul R; Kendall, Mark A F.
Affiliation
  • Muller DA; Delivery of Drugs and Genes Group (D2G2), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.
  • Pearson FE; Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia.
  • Fernando GJ; Delivery of Drugs and Genes Group (D2G2), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.
  • Agyei-Yeboah C; Delivery of Drugs and Genes Group (D2G2), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.
  • Owens NS; Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia.
  • Corrie SR; Delivery of Drugs and Genes Group (D2G2), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.
  • Crichton ML; Delivery of Drugs and Genes Group (D2G2), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.
  • Wei JC; Delivery of Drugs and Genes Group (D2G2), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.
  • Weldon WC; Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia.
  • Oberste MS; Delivery of Drugs and Genes Group (D2G2), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.
  • Young PR; Delivery of Drugs and Genes Group (D2G2), Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.
  • Kendall MA; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Sci Rep ; 6: 22094, 2016 Feb 25.
Article in En | MEDLINE | ID: mdl-26911254
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Poliovirus Vaccine, Inactivated / Vaccination / Poliovirus / Antibodies, Neutralizing / Antibodies, Viral / Antibody Formation Limits: Animals Language: En Journal: Sci Rep Year: 2016 Document type: Article Affiliation country: Australia Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Poliovirus Vaccine, Inactivated / Vaccination / Poliovirus / Antibodies, Neutralizing / Antibodies, Viral / Antibody Formation Limits: Animals Language: En Journal: Sci Rep Year: 2016 Document type: Article Affiliation country: Australia Country of publication: United kingdom